Design of implementation studies for quality improvement programs: An effectiveness-cost-effectiveness framework

American Journal of Public Health

Volumn 104, Issue 1, 2014, Pages

  Cheung, Ken ^a   Duan, Naihua ^b,c  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST BENEFIT ANALYSIS; ECONOMICS; EVIDENCE BASED MEDICINE; HUMAN; METHODOLOGY; PROCEDURES; PROGRAM DEVELOPMENT; TOTAL QUALITY MANAGEMENT; TRANSLATIONAL RESEARCH; ARTICLE;

COST-BENEFIT ANALYSIS; EVIDENCE-BASED MEDICINE; HUMANS; PROGRAM DEVELOPMENT; QUALITY IMPROVEMENT; RESEARCH DESIGN; TRANSLATIONAL MEDICAL RESEARCH;

EID: 84891718976     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301579     Document Type: Article

References (22)

1. Fogarty International Center. Implementation science information and resources. Available at: http://www.fic.nih.gov/ResearchTopics/Pages/ Implementation Science.aspx. Accessed June 10, 2013.
2. Health Resources and Services Administration. Quality improvement. Available at: http://www.hrsa gov/healthit/toolbox/healthitadoptiontoolbox/ qualityimprovement/qualityimprovementhtml. Accessed June 10, 2013.
3. US Department of Health and Human Services. Code of Federal Regulations, 45 CFR 46.102 (d). Available at: http://www.hhs.gov/ohrp/humansubjects/guidance/ 45cfr46.html#46.102. Accessed June 10, 2013.
4. West SG, Duan N, Pequegnat W, et al. Alternative to the randomized controlled trials. Am J Public Health. 2008;98(8):1359-1366.
5. Zelen M. Play the winner rule and the controlled clinical trial. J Am Stat Assoc. 1969;64:131-146.
6. Lai TL, Levin B, Robbins H, Siegmund D. Sequential medical trials. Proc Natl Acad Sci USA. 1980;77(6):3135-3138. (Pubitemid 10017422)
7. Institute of Medicine. Crossing the Quality Chasm: A New Heatlh System for the 21st Century. Washington, DC: National Academies Press; 2001.
8. Mohr DC, Cheung K, Schueller SM, Brown CH, Duan N. Continuous evaluation of evolving behavioral intervention technologies. Am J Prev Med. In press.
9. Anscombe FJ. Sequential medical trials. J Am Stat Assoc. 1963;58:365-383.
10. Bacchetti P, McCulloch CE, Segal MR. Simple, defensible sample sizes based on cost efficiency. Biometrics. 2008;64(2):577-594.
11. Fenwick E, Claxton K, Sculpher M. The value of implementation and the value of information: combined and uneven development Med Decis Making. 2008;28(1):21-32.
12. Conti S, Claxton K. Dimensions of design space: a decision-theoretic approach to optimal research design. Med Decis Making. 2009;29(6):643-660.
13. Colton T. A model for selecting one of two medical treatments. J Am Stat Assoc. 1963;58:388-400.
14. Berry DA, Eick SG. Adaptive assignment versus balanced randomization in clinical trials: a decision analysis. Stat Med. 1995;14(3):231-246.
15. Wells KB, Sherbourne C, Schoenbaum M, et al. Impact of disseminating quality improvement programs for depression to primary care: a randomized controlled trial. JAMA. 2000;283(2):212-220. (Pubitemid 30039221)
16. Willan AR, Briggs AH. Statistical Analysis of Cost-Effectiveness Data. Chichester, UK: John Wiley and Sons Ltd; 2006.
17. Savage LJ. Elicitation of personal probabilities and expectations. J Am Stat Assoc. 1971;66:783-801.
18. Bekele BN, Thall PF. Dose finding based on multiple toxicities in a soft tissue sarcoma trial. J Am Stat Assoc. 2004;99:26-35. (Pubitemid 38545191)
19. Cheung YK, Inoue LYT, Wathen K, Thall PF. Continuous Bayesian adaptive randomization based on event times with covariates. Stat Med. 2006;25(1):55-70. (Pubitemid 43136949)
20. Lee SM, Cheung YK. Calibration of prior variance in the Bayesian continual reassessment method. Stat Med. 2011;30(17):2081-2089.
21. Cheung K, Kaufmann P. Efficiency perspectives on adaptive designs in stroke clinical trials. Stroke. 2011;42(10):2990-2994.
22. Food and Drug Administration. Adaptive design clinical trials for drugs and biologics. 2010. Available at: http://www.fda.gov/downloads/drugs/ guidancecomplianceregulatoryinformation/guidances/ucm201790.pdf. Accessed June 10, 2013.